BAKER BROS ADVISORS LLC Insider Trading $MYG Mirati Therapeutics, Inc.
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in Mirati Therapeutics, Inc.
Trading Symbol: MYGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC:
Holdings: 141,244 shares
Latest Transaction: Nov 20 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in Mirati Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | Option Exercise | P | 0.00 | 1,618,684 | 1,619 | 1,618,684 | ||
Nov 20 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | Option Exercise | P | 0.00 | 304,392 | 304 | 304,392 | ||
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 5,996 | 47,129 | 0 | |
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 249,801 | 1,963,436 | 0 | |
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 7.86 | 24,466 | 192,303 | 0 | |
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 5,996 | 47,129 | 35,999 | 30 K to 36 K (+19.98 %) |
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 249,801 | 1,963,436 | 2,372,218 | 2.1 M to 2.4 M (+11.77 %) |
Nov 13 2017 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 7.86 | 24,466 | 192,303 | 141,244 | 116.8 K to 141.2 K (+20.95 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 2,318 | 22,157 | 30,003 | 32.3 K to 30 K (-7.17 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 158,684 | 1,516,797 | 2,122,417 | 2.3 M to 2.1 M (-6.96 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.56 | 9,056 | 86,563 | 116,778 | 125.8 K to 116.8 K (-7.20 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 5,111 | 48,043 | 32,321 | 37.4 K to 32.3 K (-13.65 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 349,919 | 3,289,239 | 2,281,101 | 2.6 M to 2.3 M (-13.30 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.40 | 19,970 | 187,718 | 125,834 | 145.8 K to 125.8 K (-13.70 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 2,154 | 19,844 | 37,432 | 39.6 K to 37.4 K (-5.44 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 147,529 | 1,359,096 | 2,631,020 | 2.8 M to 2.6 M (-5.31 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.21 | 8,417 | 77,541 | 145,804 | 154.2 K to 145.8 K (-5.46 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 4,201 | 39,648 | 39,586 | 43.8 K to 39.6 K (-9.59 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 275,506 | 2,600,171 | 2,778,549 | 3.1 M to 2.8 M (-9.02 %) |
Jun 09 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 9.44 | 16,493 | 155,658 | 154,221 | 170.7 K to 154.2 K (-9.66 %) |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 3,479 | 23,448 | 0 | |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 310,003 | 2,089,420 | 0 | |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 137 | 923 | 0 | |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | X | 6.74 | 137 | 923 | 0 | |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 3,479 | 23,448 | 43,787 | 40.3 K to 43.8 K (+8.63 %) |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 310,003 | 2,089,420 | 3,054,055 | 2.7 M to 3.1 M (+11.30 %) |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 137 | 923 | 137 | 0 to 137 |
Apr 01 2016 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | X | 6.74 | 137 | 923 | 137 | 0 to 137 |
Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 137 | 923 | 137 | |
Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 137 | 923 | 137 | |
Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 6.74 | 274 | 1,847 | 0 | |
Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 45.00 | 139,220 | 6,264,900 | 2,744,052 | 2.6 M to 2.7 M (+5.34 %) |
Sep 16 2015 | MYG | Mirati Therapeutic ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 45.00 | 10,780 | 485,100 | 170,714 | 159.9 K to 170.7 K (+6.74 %) |
Page: 1